New implantable continuous administration and bolus dose intracarotid drug delivery system for the treatment of malignant gliomas.
A totally implantable system for the continuous and bolus delivery of intra-arterial chemotherapeutic agents to patients with malignant gliomas is described. The system utilizes an Infusaid pump (Infusaid Corp., Sharon, Massachusetts), which discharges the drug directly into the internal carotid artery and is percutaneously refillable. This system has been utilized experimentally in primates and in the treatment of six patients with malignant gliomas. It seems that this system can be utilized safely as an experimental technique in the treatment of malignant gliomas.
D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000188:drug therapy*; D002330:Carmustine / Q000008:administration & dosage*; D002339:Carotid Arteries; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000295:instrumentation*; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage*; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D008253:Macaca mulatta; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000031:analogs & derivatives*; D008875:Middle Aged
D000970:Antineoplastic Agents; D005467:Floxuridine; C004763:3',5'-dichloromethotrexate; D002330:Carmustine; C025034:doxifluridine; D008727:Methotrexate